Provitamin D2 Compound [EPC]

Provitamin D2 Compound [EPC] was reported 29756 times

Drugs of the Provitamin D2 Compound [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 LUPUS VULGARIS 683 0.5421
1 DEEP VEIN THROMBOSIS POSTOPERATIVE 1065 0.5317
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 319 0.4775
3 C-REACTIVE PROTEIN 433 0.4671
4 RHEUMATIC FEVER 1860 0.4169
5 MYCOTIC ALLERGY 353 0.4129
6 SWOLLEN JOINT COUNT INCREASED 1228 0.3847
7 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 788 0.3799
8 FACET JOINT SYNDROME 1173 0.3599
9 DISLOCATION OF VERTEBRA 787 0.3447
10 X-RAY ABNORMAL 601 0.3358
11 RHEUMATOID FACTOR POSITIVE 1932 0.3341
12 RETINITIS 535 0.3094
13 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2199 0.3066
14 DUODENAL ULCER PERFORATION 2276 0.3057
15 DUST ALLERGY 296 0.3017
16 PERIPHERAL VENOUS DISEASE 1130 0.2764
17 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 281 0.2646
18 OBSTRUCTIVE SLEEP APNOEA SYNDROME 357 0.2447
19 HYPERPARATHYROIDISM SECONDARY 609 0.2428
20 C-REACTIVE PROTEIN ABNORMAL 1551 0.2416
21 MUSCLE INJURY 1856 0.2238
22 HELICOBACTER INFECTION 2262 0.2199
23 PEMPHIGUS 2694 0.2153
24 CONJUNCTIVITIS ALLERGIC 317 0.2139
25 NEPHROGENIC ANAEMIA 959 0.2068
26 FOLLICULITIS 2100 0.2001
27 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1276 0.1963
28 HAND DEFORMITY 2521 0.1920
29 ESSENTIAL HYPERTENSION 332 0.1812
30 BONE EROSION 638 0.1802
31 NASAL OEDEMA 313 0.1731
32 SYNOVITIS 3122 0.1730
33 BREAST CANCER STAGE III 1084 0.1672
34 INFUSION SITE DISCHARGE 280 0.1595
35 DRUG TOLERANCE DECREASED 445 0.1583
36 LIP DRY 1419 0.1561
37 PERICARDITIS 2622 0.1559
38 ONYCHOMADESIS 632 0.1504
39 BURSITIS 1827 0.1504
40 RESPIRATORY SYMPTOM 426 0.1496
41 JOINT RANGE OF MOTION DECREASED 1994 0.1485
42 WOUND INFECTION 1616 0.1474
43 HYPERCHOLESTEROLAEMIA 1396 0.1444
44 BLEPHAROSPASM 907 0.1439
45 GRIP STRENGTH DECREASED 1267 0.1438
46 VITAMIN D DECREASED 1214 0.1419
47 FIBROMYALGIA 3419 0.1405
48 CHRONIC SINUSITIS 526 0.1400
49 REBOUND ACID HYPERSECRETION 413 0.1364
50 GLOSSODYNIA 3045 0.1359
51 AUTOIMMUNE DISORDER 1325 0.1358
52 VITAMIN D DEFICIENCY 1290 0.1321
53 RADICULOPATHY 343 0.1300
54 INFUSION SITE REACTION 381 0.1274
55 EXOSTOSIS 1151 0.1259
56 ONYCHOMYCOSIS 550 0.1252
57 WALKING AID USER 826 0.1252
58 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 679 0.1246
59 WOUND 3399 0.1215
60 INFUSION SITE HAEMORRHAGE 395 0.1200
61 IRRITABLE BOWEL SYNDROME 2557 0.1191
62 PRE-EXISTING CONDITION IMPROVED 732 0.1171
63 SCIATICA 1854 0.1162
64 LIVE BIRTH 952 0.1137
65 FINGER DEFORMITY 522 0.1077
66 MUSCLE SPASTICITY 1311 0.1066
67 NORMOCHROMIC NORMOCYTIC ANAEMIA 316 0.1051
68 FULL BLOOD COUNT ABNORMAL 1105 0.1044
69 HYPERTONIC BLADDER 301 0.1041
70 MACULAR DEGENERATION 1243 0.1040
71 INFUSION SITE PRURITUS 327 0.1035
72 RHINITIS ALLERGIC 459 0.1030
73 SEASONAL ALLERGY 1447 0.1021
74 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1121 0.1012
75 OSTEOARTHRITIS 4253 0.1002
76 PROCTITIS 278 0.0991
77 SYSTEMIC LUPUS ERYTHEMATOSUS 3472 0.0977
78 NAIL DISORDER 855 0.0976
79 PSORIATIC ARTHROPATHY 3943 0.0970
80 OBESITY 1533 0.0961
81 LOWER LIMB FRACTURE 1828 0.0950
82 PULMONARY FIBROSIS 1810 0.0943
83 LIVER INJURY 2311 0.0941
84 GAIT INABILITY 3108 0.0929
85 OBSTRUCTIVE AIRWAYS DISORDER 1034 0.0929
86 CONTRAINDICATED PRODUCT ADMINISTERED 2809 0.0927
87 PLANTAR FASCIITIS 311 0.0926
88 BLOOD CALCIUM INCREASED 802 0.0914
89 WHEEZING 5412 0.0912
90 NIGHT SWEATS 2920 0.0905
91 INFUSION SITE SWELLING 570 0.0905
92 END STAGE RENAL DISEASE 1651 0.0904
93 IMPAIRED HEALING 2964 0.0902
94 SLEEP APNOEA SYNDROME 1690 0.0885
95 BACK INJURY 961 0.0883
96 FOOT DEFORMITY 972 0.0876
97 TYPE 2 DIABETES MELLITUS 2942 0.0873
98 BODY HEIGHT DECREASED 913 0.0853
99 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1450 0.0853
100 BLOOD CHOLESTEROL INCREASED 3906 0.0837
101 INFUSION SITE ERYTHEMA 706 0.0837
102 MULTIPLE ALLERGIES 651 0.0830
103 RED CELL DISTRIBUTION WIDTH INCREASED 345 0.0830
104 INTERVERTEBRAL DISC DEGENERATION 764 0.0825
105 ARTHROPATHY 4574 0.0822
106 BRONCHIECTASIS 550 0.0816
107 JOINT DISLOCATION 854 0.0807
108 EAR PAIN 1568 0.0806
109 TASTE DISORDER 1633 0.0804
110 PRODUCT ADMINISTRATION INTERRUPTED 630 0.0802
111 SPONDYLITIS 290 0.0797
112 BREATH SOUNDS ABNORMAL 389 0.0788
113 INFUSION SITE PAIN 1014 0.0786
114 SPINAL STENOSIS 324 0.0784
115 DECREASED INTEREST 462 0.0783
116 CARPAL TUNNEL SYNDROME 1093 0.0780
117 HIP ARTHROPLASTY 1192 0.0778
118 PARANASAL SINUS DISCOMFORT 292 0.0771
119 UPPER-AIRWAY COUGH SYNDROME 635 0.0770
120 SINUSITIS 7854 0.0766
121 OSTEOPENIA 1154 0.0760
122 IRON DEFICIENCY 341 0.0757
123 TRIGGER FINGER 307 0.0751
124 ULCER HAEMORRHAGE 508 0.0750
125 CHRONIC KIDNEY DISEASE 5684 0.0747
126 PRESCRIBED UNDERDOSE 1490 0.0746
127 VITAMIN B12 DEFICIENCY 302 0.0745
128 ARTERIOSCLEROSIS CORONARY ARTERY 492 0.0742
129 COMPRESSION FRACTURE 396 0.0738
130 SINUS CONGESTION 997 0.0737
131 MOBILITY DECREASED 5298 0.0737
132 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3537 0.0736
133 MENISCUS INJURY 451 0.0733
134 PERONEAL NERVE PALSY 412 0.0724
135 WEIGHT FLUCTUATION 758 0.0724
136 THYROID MASS 277 0.0721
137 FREQUENT BOWEL MOVEMENTS 1950 0.0721
138 LOWER RESPIRATORY TRACT INFECTION 3276 0.0720
139 BLOOD MAGNESIUM DECREASED 621 0.0719
140 SKIN ABRASION 340 0.0719
141 SINUS DISORDER 1424 0.0718
142 OSTEOPOROSIS 2957 0.0718
143 SPINAL OSTEOARTHRITIS 626 0.0712
144 BLOOD IRON DECREASED 832 0.0700
145 PRESCRIBED OVERDOSE 1353 0.0699
146 OEDEMA 3760 0.0693
147 HYPERCALCAEMIA 854 0.0691
148 MICTURITION URGENCY 790 0.0691
149 MUSCULOSKELETAL STIFFNESS 6053 0.0690
150 GASTROOESOPHAGEAL REFLUX DISEASE 5531 0.0686
151 BLOOD TEST ABNORMAL 964 0.0685
152 SPINAL FUSION SURGERY 278 0.0685
153 URINE ABNORMALITY 311 0.0683
154 LUPUS-LIKE SYNDROME 620 0.0683
155 MUSCULOSKELETAL PAIN 3548 0.0677
156 SENSORY LOSS 545 0.0676
157 HEPATIC ENZYME INCREASED 4559 0.0668
158 RESPIRATORY TRACT CONGESTION 1062 0.0668
159 RASH VESICULAR 323 0.0667
160 BLISTER 3739 0.0665
161 BLOOD CALCIUM DECREASED 745 0.0662
162 SYNOVIAL CYST 305 0.0660
163 LUMBAR VERTEBRAL FRACTURE 302 0.0658
164 WRIST FRACTURE 788 0.0657
165 INFUSION RELATED REACTION 4349 0.0655
166 STRESS FRACTURE 353 0.0654
167 HAEMORRHAGIC ANAEMIA 287 0.0652
168 NODULE 849 0.0650
169 THERAPEUTIC PRODUCT EFFECT DECREASED 2910 0.0649
170 LYMPHOEDEMA 449 0.0649
171 STOMATITIS 3933 0.0648
172 CONTUSION 6228 0.0646
173 PRODUCTIVE COUGH 3077 0.0644
174 KNEE ARTHROPLASTY 1344 0.0638
175 PULMONARY MASS 947 0.0635
176 NOCTURIA 770 0.0634
177 JOINT SWELLING 7652 0.0633
178 FAECES SOFT 461 0.0633
179 PERIPHERAL SWELLING 9752 0.0632
180 INCREASED TENDENCY TO BRUISE 580 0.0630
181 TENDERNESS 656 0.0629
182 RHINITIS 506 0.0627
183 LIGAMENT SPRAIN 616 0.0622
184 BLOOD PRESSURE DIASTOLIC DECREASED 459 0.0621
185 NERVE COMPRESSION 573 0.0620
186 LIVER FUNCTION TEST INCREASED 1331 0.0619
187 RHEUMATOID ARTHRITIS 7026 0.0618
188 COELIAC DISEASE 607 0.0618
189 EAR INFECTION 1645 0.0618
190 SPUTUM DISCOLOURED 585 0.0616
191 ARTERIOSCLEROSIS 580 0.0616
192 NECK PAIN 3439 0.0615
193 PATHOLOGICAL FRACTURE 312 0.0614
194 VASCULAR DEVICE INFECTION 278 0.0612
195 CYSTITIS 1948 0.0611
196 UPPER RESPIRATORY TRACT INFECTION 2824 0.0611
197 LARGE INTESTINE POLYP 423 0.0610
198 HEPATIC ENZYME ABNORMAL 304 0.0609
199 ONYCHOCLASIS 419 0.0608
200 GINGIVAL PAIN 484 0.0608
201 BALANCE DISORDER 5256 0.0607
202 BLOOD PRESSURE FLUCTUATION 1459 0.0607
203 RESPIRATORY TRACT INFECTION 1580 0.0606
204 PELVIC FRACTURE 472 0.0606
205 ANAL INCONTINENCE 545 0.0605
206 ARTHROPOD BITE 449 0.0605
207 DISCOMFORT 3684 0.0603
208 SCOLIOSIS 373 0.0602
209 SPINAL COMPRESSION FRACTURE 495 0.0598
210 DRY MOUTH 4856 0.0598
211 FOOT FRACTURE 1134 0.0598
212 ENDOMETRIOSIS 285 0.0597
213 BOWEL MOVEMENT IRREGULARITY 457 0.0596
214 CYSTIC FIBROSIS 330 0.0595
215 TIBIA FRACTURE 279 0.0594
216 SLEEP DISORDER 4197 0.0594
217 JOINT STIFFNESS 1559 0.0594
218 ROTATOR CUFF SYNDROME 763 0.0594
219 PARAESTHESIA ORAL 855 0.0592
220 MUSCULAR WEAKNESS 6696 0.0589
221 EXERCISE TOLERANCE DECREASED 339 0.0588
222 HEPATIC CIRRHOSIS 1103 0.0586
223 RIB FRACTURE 1207 0.0586
224 BACK DISORDER 954 0.0586
225 ARTHRITIS 4602 0.0584
226 TOOTH INFECTION 770 0.0584
227 BLOOD PRESSURE SYSTOLIC INCREASED 1138 0.0583
228 TEMPERATURE INTOLERANCE 601 0.0582
229 ANKLE FRACTURE 899 0.0580
230 HYPOAESTHESIA 8689 0.0580
231 HUMERUS FRACTURE 279 0.0578
232 SWELLING 5411 0.0578
233 LUNG DISORDER 2828 0.0576
234 SKIN LACERATION 626 0.0575
235 DYSLIPIDAEMIA 292 0.0574
236 BRAIN FOG 898 0.0572
237 HYPERVOLAEMIA 283 0.0572
238 NEURALGIA 1390 0.0571
239 SQUAMOUS CELL CARCINOMA OF SKIN 345 0.0571
240 SECRETION DISCHARGE 712 0.0568
241 PRODUCT LABEL CONFUSION 331 0.0567
242 POOR VENOUS ACCESS 587 0.0567
243 URINE ODOUR ABNORMAL 333 0.0566
244 DIZZINESS POSTURAL 549 0.0566
245 GASTROENTERITIS VIRAL 1022 0.0565
246 BODY TEMPERATURE DECREASED 556 0.0564
247 C-REACTIVE PROTEIN INCREASED 2051 0.0563
248 ASTHMA 6361 0.0562
249 LYMPHOCYTE COUNT DECREASED 994 0.0562
250 GLUCOSE TOLERANCE IMPAIRED 332 0.0561
251 MUCOUS STOOLS 278 0.0561
252 BLADDER DISORDER 556 0.0559
253 DYSPEPSIA 5505 0.0559
254 APPETITE DISORDER 370 0.0558
255 BRONCHITIS 4131 0.0558
256 HOSPICE CARE 550 0.0556
257 LIMB DISCOMFORT 1722 0.0556
258 SPINAL FRACTURE 1115 0.0556
259 MUSCLE STRAIN 481 0.0555
260 INFLAMMATION 2869 0.0555
261 INTERVERTEBRAL DISC PROTRUSION 1215 0.0555
262 ABDOMINAL DISCOMFORT 9312 0.0555
263 FULL BLOOD COUNT DECREASED 1118 0.0554
264 GAIT DISTURBANCE 10571 0.0552
265 DYSPNOEA EXERTIONAL 2076 0.0551
266 DRUG INTOLERANCE 5324 0.0551
267 RED BLOOD CELL COUNT DECREASED 1575 0.0550
268 MUSCULOSKELETAL DISCOMFORT 947 0.0550
269 HAND FRACTURE 389 0.0549
270 MULTIPLE SCLEROSIS RELAPSE 3754 0.0547
271 INFUSION SITE EXTRAVASATION 340 0.0546
272 NEUROLOGICAL SYMPTOM 312 0.0545
273 NASOPHARYNGITIS 10059 0.0545
274 RHINORRHOEA 3527 0.0545
275 MUSCULOSKELETAL CHEST PAIN 843 0.0544
276 DERMATITIS CONTACT 620 0.0543
277 PAIN IN JAW 1540 0.0543
278 BLOOD POTASSIUM DECREASED 1634 0.0543
279 HEART RATE DECREASED 1908 0.0543
280 CONCUSSION 420 0.0542
281 RALES 315 0.0542
282 GASTROINTESTINAL DISORDER 4844 0.0540
283 TOOTH ABSCESS 550 0.0540
284 BODY TEMPERATURE INCREASED 1101 0.0539
285 GROIN PAIN 473 0.0538
286 RESTLESS LEGS SYNDROME 977 0.0537
287 HOT FLUSH 4044 0.0536
288 JOINT EFFUSION 368 0.0533
289 URINARY TRACT INFECTION 9101 0.0533
290 DYSSTASIA 1555 0.0532
291 CENTRAL NERVOUS SYSTEM LESION 731 0.0531
292 SKIN ATROPHY 306 0.0531
293 MIGRAINE 5056 0.0529
294 ORAL PAIN 1185 0.0529
295 HIATUS HERNIA 685 0.0529
296 MUSCLE SPASMS 9691 0.0528
297 ORAL CANDIDIASIS 694 0.0527
298 MOTOR DYSFUNCTION 537 0.0526
299 EYE PAIN 2970 0.0526
300 EYE INFECTION 594 0.0526
301 HYPERLIPIDAEMIA 624 0.0522
302 FALL 17344 0.0521
303 CLOSTRIDIUM DIFFICILE INFECTION 1135 0.0519
304 SMALL INTESTINAL OBSTRUCTION 640 0.0519
305 ROAD TRAFFIC ACCIDENT 2171 0.0518
306 HYPERKERATOSIS 286 0.0518
307 INSURANCE ISSUE 791 0.0517
308 NEPHROLITHIASIS 2372 0.0517
309 RENAL CYST 409 0.0514
310 PAIN IN EXTREMITY 15167 0.0514
311 BONE PAIN 3015 0.0514
312 JOINT INJURY 1099 0.0514
313 ARTERIAL OCCLUSIVE DISEASE 404 0.0513
314 DEFAECATION URGENCY 360 0.0513
315 BASAL CELL CARCINOMA 799 0.0512
316 BLOOD COUNT ABNORMAL 775 0.0511
317 IRON DEFICIENCY ANAEMIA 471 0.0510
318 SKIN WARM 295 0.0507
319 BACK PAIN 11776 0.0506
320 DIVERTICULITIS 1403 0.0506
321 MEMORY IMPAIRMENT 6939 0.0505
322 HYPOPHOSPHATAEMIA 373 0.0504
323 THYROID DISORDER 775 0.0502
324 SKIN HAEMORRHAGE 745 0.0502
325 NASAL CONGESTION 2952 0.0502
326 POOR QUALITY SLEEP 1081 0.0502
327 INTENTIONAL PRODUCT USE ISSUE 4398 0.0502
328 HAIR TEXTURE ABNORMAL 670 0.0500
329 BREAST CANCER STAGE II 416 0.0500
330 SINUS HEADACHE 297 0.0499
331 GOUT 896 0.0499
332 POLLAKIURIA 2080 0.0498
333 SNEEZING 1117 0.0498
334 RESPIRATORY DISORDER 1489 0.0497
335 FATIGUE 38753 0.0497
336 GASTROINTESTINAL PAIN 546 0.0496
337 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3526 0.0495
338 HEAD DISCOMFORT 877 0.0495
339 ARTHRALGIA 20586 0.0495
340 HIP FRACTURE 1588 0.0493
341 CYST 611 0.0492
342 TOOTHACHE 888 0.0490
343 DRY THROAT 498 0.0489
344 PAROSMIA 369 0.0489
345 LIMB INJURY 1328 0.0488
346 FLANK PAIN 458 0.0488
347 FACIAL PAIN 436 0.0488
348 CATARACT 2908 0.0488
349 INITIAL INSOMNIA 501 0.0488
350 UPPER LIMB FRACTURE 972 0.0487
351 TOOTH FRACTURE 537 0.0487
352 MUSCLE TIGHTNESS 787 0.0485
353 TOOTH DISORDER 1079 0.0485
354 HAEMATOCRIT DECREASED 962 0.0485
355 ALOPECIA 9525 0.0485
356 MIDDLE INSOMNIA 904 0.0484
357 SPINAL PAIN 565 0.0482
358 PARAESTHESIA 7574 0.0481
359 FLUSHING 4877 0.0479
360 ABNORMAL FAECES 393 0.0479
361 POST PROCEDURAL INFECTION 390 0.0479
362 OCULAR DISCOMFORT 538 0.0479
363 DENTAL CARIES 530 0.0479
364 CONSTIPATION 10439 0.0478
365 COLITIS ULCERATIVE 2132 0.0476
366 GASTROINTESTINAL INFECTION 427 0.0476
367 EAR DISCOMFORT 486 0.0473
368 HYPOTHYROIDISM 1512 0.0473
369 DIVERTICULUM 336 0.0472
370 HEART RATE IRREGULAR 1065 0.0471
371 HYPERSOMNIA 1351 0.0471
372 URINARY INCONTINENCE 1394 0.0470
373 THERAPY CESSATION 2413 0.0470
374 MULTIPLE SCLEROSIS 2246 0.0469
375 PHOTOPHOBIA 883 0.0469
376 BLOOD PRESSURE ABNORMAL 933 0.0469
377 NASAL DRYNESS 294 0.0469
378 GLOMERULAR FILTRATION RATE DECREASED 576 0.0468
379 BLOOD PRESSURE INCREASED 7159 0.0468
380 BONE DISORDER 853 0.0468
381 ASTHENIA 17575 0.0467
382 FLATULENCE 2648 0.0466
383 CARDIAC MURMUR 404 0.0466
384 ABDOMINAL PAIN UPPER 9597 0.0466
385 COUGH 13064 0.0465
386 OROPHARYNGEAL PAIN 4305 0.0465
387 TENDONITIS 720 0.0465
388 BREAST MASS 312 0.0464
389 APHTHOUS ULCER 360 0.0464
390 TENDON PAIN 351 0.0463
391 INCONTINENCE 490 0.0463
392 CONCOMITANT DISEASE AGGRAVATED 285 0.0461
393 WEIGHT DECREASED 12871 0.0461
394 BLOOD URINE PRESENT 875 0.0460
395 HEAD INJURY 1456 0.0460
396 FEELING HOT 2817 0.0459
397 THERAPY NON-RESPONDER 2057 0.0457
398 COORDINATION ABNORMAL 637 0.0456
399 POLYP 298 0.0455
400 ABDOMINAL DISTENSION 4749 0.0454
401 CLOSTRIDIUM DIFFICILE COLITIS 482 0.0454
402 LOCALISED INFECTION 1099 0.0454
403 DRY EYE 2267 0.0454
404 FLUID RETENTION 2310 0.0454
405 HYPERTENSION 9603 0.0453
406 RECTAL HAEMORRHAGE 1947 0.0453
407 HAIR DISORDER 373 0.0452
408 EATING DISORDER 960 0.0450
409 WEIGHT INCREASED 10081 0.0450
410 INSOMNIA 11954 0.0448
411 VIRAL INFECTION 1491 0.0448
412 HAEMORRHOIDS 872 0.0447
413 HAIR COLOUR CHANGES 555 0.0446
414 CARDIAC FLUTTER 288 0.0445
415 HAIR GROWTH ABNORMAL 308 0.0445
416 BLOOD ALBUMIN DECREASED 353 0.0445
417 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 759 0.0442
418 BLOOD POTASSIUM INCREASED 718 0.0442
419 INFLUENZA 4931 0.0442
420 ULCER 703 0.0441
421 DYSPHONIA 2580 0.0441
422 HERNIA 852 0.0440
423 FEELING COLD 1226 0.0440
424 ATELECTASIS 425 0.0439
425 GLAUCOMA 847 0.0439
426 NERVE INJURY 488 0.0438
427 BURNING SENSATION 3069 0.0437
428 DECREASED ACTIVITY 471 0.0436
429 HEMIPARESIS 738 0.0435
430 RESPIRATORY SYNCYTIAL VIRUS INFECTION 379 0.0435
431 HYPOCALCAEMIA 823 0.0434
432 AMNESIA 2822 0.0433
433 WHITE BLOOD CELL COUNT DECREASED 4701 0.0433
434 DECREASED APPETITE 10064 0.0433
435 CELLULITIS 2181 0.0432
436 DEPRESSION 9837 0.0432
437 IMMUNODEFICIENCY 644 0.0432
438 NEUROPATHY PERIPHERAL 4103 0.0431
439 FEMUR FRACTURE 1335 0.0431
440 PNEUMONIA 13934 0.0430
441 INFLUENZA LIKE ILLNESS 3537 0.0429
442 HEPATIC STEATOSIS 800 0.0429
443 BLOOD SODIUM DECREASED 809 0.0429
444 IMPAIRED GASTRIC EMPTYING 585 0.0429
445 PRODUCT DISTRIBUTION ISSUE 398 0.0429
446 DIARRHOEA 27687 0.0428
447 BLOOD THYROID STIMULATING HORMONE INCREASED 394 0.0428
448 CHEST PAIN 7927 0.0428
449 NEPHROPATHY 399 0.0427
450 VITREOUS FLOATERS 420 0.0427
451 LABORATORY TEST ABNORMAL 1258 0.0426
452 MYOSITIS 382 0.0425
453 HEADACHE 26588 0.0424
454 RASH PRURITIC 2294 0.0423
455 HAEMATOCHEZIA 2331 0.0422
456 POSTOPERATIVE WOUND INFECTION 285 0.0422
457 KIDNEY INFECTION 828 0.0422
458 FUNGAL INFECTION 1404 0.0421
459 OXYGEN SATURATION DECREASED 2367 0.0421
460 IMMUNE SYSTEM DISORDER 555 0.0421
461 UROSEPSIS 388 0.0420
462 HERPES ZOSTER 2416 0.0420
463 CONFUSIONAL STATE 6795 0.0420
464 SENSATION OF FOREIGN BODY 354 0.0420
465 LACRIMATION INCREASED 1269 0.0420
466 HYPERAESTHESIA 345 0.0420
467 SPINAL DISORDER 397 0.0419
468 MUSCULOSKELETAL DISORDER 795 0.0417
469 GASTROINTESTINAL INFLAMMATION 327 0.0417
470 LIVER DISORDER 1849 0.0417
471 HEART RATE INCREASED 4121 0.0416
472 THROAT IRRITATION 1866 0.0415
473 PERIPHERAL COLDNESS 571 0.0415
474 HYSTERECTOMY 360 0.0415
475 INFECTION 6005 0.0414
476 CHILLS 4855 0.0414
477 SKIN INFECTION 464 0.0413
478 PHARYNGITIS STREPTOCOCCAL 447 0.0413
479 IMPAIRED WORK ABILITY 880 0.0411
480 CHEST DISCOMFORT 4206 0.0410
481 ATAXIA 487 0.0410
482 RETCHING 874 0.0410
483 MUSCLE ATROPHY 519 0.0409
484 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2129 0.0408
485 OEDEMA PERIPHERAL 4970 0.0407
486 UTERINE LEIOMYOMA 297 0.0406
487 COVID-19 7118 0.0405
488 SENSORY DISTURBANCE 651 0.0405
489 DIZZINESS 20138 0.0403
490 INJURY 2837 0.0403
491 MOVEMENT DISORDER 1295 0.0403
492 DECUBITUS ULCER 328 0.0402
493 MYASTHENIA GRAVIS 325 0.0402
494 PAIN 24693 0.0402
495 ADVERSE REACTION 533 0.0402
496 HAEMOPTYSIS 1121 0.0401
497 TINNITUS 1843 0.0401
498 FRUSTRATION TOLERANCE DECREASED 324 0.0401
499 PALPITATIONS 4694 0.0400
500 MASS 559 0.0400
501 DYSURIA 1472 0.0400
502 FEELING JITTERY 762 0.0399
503 PLATELET COUNT INCREASED 520 0.0398
504 ORAL DISORDER 292 0.0398
505 FOOD ALLERGY 306 0.0396
506 SPINAL OPERATION 488 0.0396
507 SKIN DISCOLOURATION 1820 0.0396
508 HEMIPLEGIA 329 0.0395
509 DISABILITY 782 0.0395
510 MALNUTRITION 442 0.0395
511 SLUGGISHNESS 402 0.0394
512 PRODUCT DOSE OMISSION IN ERROR 1116 0.0394
513 ATRIAL FIBRILLATION 3837 0.0394
514 ILL-DEFINED DISORDER 2389 0.0393
515 TOOTH EXTRACTION 489 0.0393
516 FEEDING DISORDER 796 0.0392
517 GENERAL SYMPTOM 294 0.0392
518 SCAB 447 0.0392
519 MYALGIA 6660 0.0391
520 EOSINOPHIL COUNT INCREASED 326 0.0391
521 IMPAIRED QUALITY OF LIFE 562 0.0391
522 PROCEDURAL PAIN 1084 0.0390
523 WHITE BLOOD CELL COUNT INCREASED 1499 0.0390
524 HYPOPHAGIA 998 0.0390
525 DEHYDRATION 5198 0.0389
526 AGEUSIA 971 0.0389
527 ERUCTATION 753 0.0389
528 MUSCLE DISORDER 314 0.0387
529 CONDITION AGGRAVATED 11778 0.0387
530 ACUTE RESPIRATORY FAILURE 745 0.0387
531 TROPONIN INCREASED 294 0.0386
532 SARS-COV-2 TEST POSITIVE 510 0.0386
533 AFFECT LABILITY 371 0.0385
534 THERAPY CHANGE 379 0.0385
535 INTENTIONAL DOSE OMISSION 1095 0.0384
536 APHONIA 536 0.0384
537 CHROMATURIA 866 0.0383
538 ATRIAL FLUTTER 306 0.0383
539 ANXIETY 10901 0.0383
540 THERAPEUTIC RESPONSE UNEXPECTED 1718 0.0383
541 CEREBRAL DISORDER 283 0.0382
542 QUALITY OF LIFE DECREASED 513 0.0382
543 CANDIDA INFECTION 642 0.0380
544 APHASIA 1148 0.0380
545 ORAL HERPES 742 0.0380
546 TUBULOINTERSTITIAL NEPHRITIS 711 0.0379
547 ABDOMINAL PAIN 8803 0.0378
548 SCRATCH 399 0.0378
549 SKIN LESION 1036 0.0377
550 URTICARIA 6326 0.0377
551 FAECES DISCOLOURED 817 0.0376
552 VAGINAL DISCHARGE 381 0.0376
553 FURUNCLE 298 0.0376
554 TREATMENT FAILURE 3113 0.0375
555 COGNITIVE DISORDER 1753 0.0375
556 SQUAMOUS CELL CARCINOMA 353 0.0375
557 DELIRIUM 1301 0.0374
558 BACTERIAL INFECTION 699 0.0374
559 SKIN ULCER 967 0.0374
560 PROSTATIC SPECIFIC ANTIGEN INCREASED 515 0.0373
561 PULMONARY THROMBOSIS 407 0.0373
562 GENERAL PHYSICAL HEALTH DETERIORATION 4316 0.0373
563 PULMONARY HYPERTENSION 776 0.0372
564 LACERATION 350 0.0372
565 LOW DENSITY LIPOPROTEIN INCREASED 288 0.0372
566 HYPOKINESIA 540 0.0372
567 THIRST 664 0.0371
568 DYSPNOEA 21036 0.0371
569 EYE DISCHARGE 386 0.0371
570 EPISTAXIS 2777 0.0371
571 FEELING ABNORMAL 8895 0.0371
572 TENDON RUPTURE 458 0.0371
573 DEPRESSED MOOD 1958 0.0370
574 VASCULITIS 430 0.0369
575 OSTEOMYELITIS 668 0.0369
576 MUSCLE TWITCHING 848 0.0368
577 ILLNESS 3789 0.0367
578 HYPERSENSITIVITY 6822 0.0367
579 HAEMOGLOBIN DECREASED 3771 0.0367
580 URINE OUTPUT DECREASED 321 0.0367
581 RENAL DISORDER 1708 0.0366
582 VERTIGO 2231 0.0366
583 CHOLECYSTECTOMY 417 0.0365
584 INTESTINAL OBSTRUCTION 1375 0.0364
585 BEDRIDDEN 479 0.0364
586 HEREDITARY ANGIOEDEMA 391 0.0364
587 CONGENITAL ANOMALY 282 0.0364
588 PHARYNGEAL SWELLING 356 0.0363
589 NAUSEA 28747 0.0363
590 CORONARY ARTERY OCCLUSION 498 0.0363
591 DIPLOPIA 943 0.0363
592 NASAL DISCOMFORT 287 0.0362
593 POST PROCEDURAL COMPLICATION 695 0.0362
594 PRURITUS 13889 0.0361
595 ORAL DISCOMFORT 501 0.0360
596 COLITIS 1365 0.0360
597 HYPOXIA 1268 0.0360
598 MATERNAL EXPOSURE DURING PREGNANCY 3208 0.0360
599 PHOTOSENSITIVITY REACTION 590 0.0357
600 THROMBOSIS 2874 0.0357
601 TREMOR 5909 0.0356
602 BLOOD PRESSURE DECREASED 2362 0.0355
603 RESPIRATORY RATE INCREASED 315 0.0354
604 BREAST PAIN 378 0.0354
605 IMPAIRED DRIVING ABILITY 402 0.0353
606 AFFECTIVE DISORDER 278 0.0353
607 IMMUNOSUPPRESSION 311 0.0352
608 LYMPHADENOPATHY 1243 0.0351
609 OROPHARYNGEAL DISCOMFORT 316 0.0349
610 MADAROSIS 405 0.0349
611 OPTIC NEURITIS 317 0.0349
612 DYSGEUSIA 2591 0.0348
613 GASTRITIS 917 0.0348
614 DYSPHAGIA 3304 0.0348
615 ORTHOSTATIC HYPOTENSION 606 0.0348
616 RENAL PAIN 368 0.0347
617 RENAL INJURY 1030 0.0346
618 PNEUMONIA BACTERIAL 318 0.0346
619 VOMITING 16234 0.0345
620 DRUG LEVEL DECREASED 350 0.0344
621 VISION BLURRED 4719 0.0343
622 SKIN DISORDER 1146 0.0343
623 FISTULA 386 0.0343
624 MALAISE 15059 0.0343
625 RENAL FAILURE 4555 0.0343
626 COVID-19 PNEUMONIA 405 0.0343
627 HYPOAESTHESIA ORAL 516 0.0342
628 INCREASED APPETITE 654 0.0342
629 EPILEPSY 1046 0.0342
630 TRANSFUSION 358 0.0341
631 MITRAL VALVE INCOMPETENCE 384 0.0339
632 OVARIAN CYST 339 0.0339
633 GALLBLADDER DISORDER 604 0.0338
634 CHOKING 660 0.0338
635 PRODUCT USE COMPLAINT 531 0.0337
636 PRODUCT SUBSTITUTION ISSUE 1940 0.0337
637 DRUG EFFECT LESS THAN EXPECTED 499 0.0336
638 PRESYNCOPE 817 0.0336
639 VISUAL IMPAIRMENT 4162 0.0336
640 DECREASED IMMUNE RESPONSIVENESS 329 0.0335
641 EMPHYSEMA 337 0.0334
642 BLOOD CREATININE INCREASED 2181 0.0334
643 BLOOD UREA INCREASED 559 0.0334
644 PRODUCT USE ISSUE 6264 0.0333
645 CHOLELITHIASIS 1093 0.0333
646 APPENDICITIS 311 0.0333
647 RASH 14514 0.0333
648 PYREXIA 11465 0.0331
649 PNEUMOTHORAX 525 0.0331
650 DYSARTHRIA 1240 0.0329
651 EYE INFLAMMATION 314 0.0329
652 EYE DISORDER 1082 0.0329
653 ASPIRATION 360 0.0328
654 TRANSIENT ISCHAEMIC ATTACK 1106 0.0327
655 SKIN FISSURES 640 0.0327
656 SURGERY 1919 0.0327
657 SCAR 558 0.0326
658 NERVOUSNESS 1701 0.0325
659 NEUTROPHIL COUNT INCREASED 333 0.0325
660 ANKYLOSING SPONDYLITIS 428 0.0324
661 RASH MACULAR 1131 0.0323
662 SKIN CANCER 696 0.0323
663 ACUTE KIDNEY INJURY 4930 0.0322
664 EYE IRRITATION 1854 0.0322
665 PHARYNGITIS 399 0.0321
666 EYE SWELLING 1196 0.0321
667 STAPHYLOCOCCAL INFECTION 1059 0.0321
668 SPLENOMEGALY 376 0.0321
669 HUNGER 446 0.0320
670 DISTURBANCE IN ATTENTION 1724 0.0319
671 CRYING 1161 0.0319
672 PNEUMONIA ASPIRATION 793 0.0317
673 PANIC ATTACK 1156 0.0317
674 KNEE OPERATION 312 0.0317
675 SPEECH DISORDER 1660 0.0317
676 SOMNOLENCE 6369 0.0316
677 HALLUCINATION 2383 0.0316
678 INTERNAL HAEMORRHAGE 361 0.0316
679 DIARRHOEA HAEMORRHAGIC 295 0.0315
680 BONE DENSITY DECREASED 988 0.0315
681 VENTRICULAR EXTRASYSTOLES 327 0.0315
682 THINKING ABNORMAL 586 0.0314
683 GASTRIC DISORDER 1079 0.0314
684 EYE HAEMORRHAGE 419 0.0314
685 PRODUCT DOSE OMISSION ISSUE 9232 0.0314
686 PREGNANCY 626 0.0312
687 LETHARGY 1795 0.0312
688 RASH PAPULAR 699 0.0312
689 PRURITUS GENERALISED 673 0.0311
690 PLATELET COUNT DECREASED 3311 0.0310
691 PRODUCT DOSE OMISSION 2024 0.0310
692 DELUSION 481 0.0309
693 ADVERSE DRUG REACTION 2779 0.0309
694 OESOPHAGITIS 338 0.0309
695 HYPERHIDROSIS 3984 0.0309
696 ABASIA 761 0.0308
697 THERAPY INTERRUPTED 2198 0.0307
698 BLOOD ALKALINE PHOSPHATASE INCREASED 760 0.0306
699 HYPOACUSIS 1310 0.0304
700 ANAEMIA 5795 0.0304
701 GINGIVAL BLEEDING 414 0.0303
702 GASTROENTERITIS 442 0.0303
703 ABSCESS 483 0.0302
704 DEAFNESS 790 0.0302
705 PETECHIAE 315 0.0302
706 RENAL TUBULAR NECROSIS 294 0.0299
707 DRUG-INDUCED LIVER INJURY 940 0.0299
708 LOCAL SWELLING 522 0.0299
709 DEMENTIA 835 0.0298
710 PULMONARY CONGESTION 393 0.0298
711 ACTIVITIES OF DAILY LIVING IMPAIRED 586 0.0296
712 MOUTH ULCERATION 622 0.0295
713 COLD SWEAT 520 0.0295
714 SKIN EXFOLIATION 2488 0.0295
715 BLOOD TRIGLYCERIDES INCREASED 521 0.0295
716 MALIGNANT MELANOMA 395 0.0295
717 INJECTION SITE BRUISING 2351 0.0294
718 PSORIASIS 3844 0.0294
719 SWOLLEN TONGUE 913 0.0292
720 CONJUNCTIVITIS 541 0.0291
721 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5252 0.0291
722 SWELLING FACE 1896 0.0291
723 THERAPEUTIC RESPONSE SHORTENED 965 0.0291
724 THROAT TIGHTNESS 787 0.0291
725 EYE PRURITUS 977 0.0290
726 URINARY RETENTION 968 0.0290
727 DYSKINESIA 1176 0.0289
728 OCULAR HYPERAEMIA 1368 0.0288
729 PLASMA CELL MYELOMA 1116 0.0286
730 HYPOMAGNESAEMIA 397 0.0285
731 UNEVALUABLE EVENT 2146 0.0283
732 HEPATITIS 725 0.0283
733 BIPOLAR DISORDER 306 0.0281
734 ADRENAL INSUFFICIENCY 341 0.0281
735 MENTAL IMPAIRMENT 681 0.0281
736 INJECTION SITE REACTION 1925 0.0279
737 ELECTROLYTE IMBALANCE 324 0.0279
738 ECONOMIC PROBLEM 422 0.0278
739 PLEURAL EFFUSION 1693 0.0278
740 INJECTION SITE DISCOLOURATION 341 0.0273
741 METASTASES TO BONE 446 0.0271
742 EXPOSURE DURING PREGNANCY 1688 0.0271
743 OFF LABEL USE 23725 0.0271
744 LIP SWELLING 902 0.0271
745 ANOSMIA 391 0.0270
746 INJECTION SITE PRURITUS 1807 0.0269
747 CARDIOMEGALY 331 0.0269
748 NIGHTMARE 929 0.0268
749 GASTRIC ULCER 510 0.0268
750 LYMPHOPENIA 379 0.0268
751 DRY SKIN 3575 0.0268
752 PERICARDIAL EFFUSION 619 0.0267
753 ERYTHEMA 5502 0.0267
754 SKIN REACTION 377 0.0267
755 ANHEDONIA 701 0.0266
756 CORONARY ARTERY DISEASE 805 0.0266
757 DEEP VEIN THROMBOSIS 1723 0.0265
758 LOSS OF CONSCIOUSNESS 3390 0.0264
759 PULMONARY EMBOLISM 2511 0.0264
760 SYNCOPE 2635 0.0263
761 CARDIAC DISORDER 2460 0.0263
762 BACTERAEMIA 311 0.0262
763 LUNG INFECTION 407 0.0262
764 UPPER GASTROINTESTINAL HAEMORRHAGE 440 0.0261
765 RASH ERYTHEMATOUS 1245 0.0260
766 ABDOMINAL PAIN LOWER 658 0.0260
767 CARDIAC FAILURE CONGESTIVE 2090 0.0260
768 INJECTION SITE INDURATION 337 0.0260
769 INJECTION SITE NODULE 286 0.0260
770 HYPOTENSION 5202 0.0259
771 INJECTION SITE URTICARIA 635 0.0259
772 SEPSIS 2885 0.0258
773 SEIZURE 2986 0.0258
774 FRACTURE 489 0.0258
775 APATHY 375 0.0257
776 DEVICE RELATED INFECTION 395 0.0256
777 DRUG DOSE OMISSION 4237 0.0256
778 INJECTION SITE MASS 946 0.0256
779 BLINDNESS UNILATERAL 359 0.0254
780 DEVICE OCCLUSION 358 0.0254
781 LEUKOCYTOSIS 460 0.0254
782 HALLUCINATION, VISUAL 536 0.0254
783 MENTAL STATUS CHANGES 705 0.0254
784 RENAL IMPAIRMENT 2130 0.0253
785 INJECTION SITE HAEMATOMA 365 0.0251
786 HOSPITALISATION 3852 0.0250
787 ABNORMAL DREAMS 691 0.0250
788 FEAR 673 0.0250
789 MOOD ALTERED 682 0.0250
790 ECZEMA 1308 0.0250
791 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1772 0.0249
792 DISORIENTATION 987 0.0249
793 DIABETES MELLITUS 1881 0.0247
794 INJECTION SITE RASH 754 0.0246
795 HAEMATOMA 635 0.0245
796 PRODUCT USE IN UNAPPROVED INDICATION 6066 0.0245
797 PULMONARY OEDEMA 1096 0.0244
798 ANGINA PECTORIS 700 0.0244
799 DERMATITIS ALLERGIC 307 0.0244
800 IRRITABILITY 1467 0.0244
801 ALANINE AMINOTRANSFERASE INCREASED 1497 0.0244
802 POST PROCEDURAL HAEMORRHAGE 283 0.0243
803 ASPARTATE AMINOTRANSFERASE INCREASED 1291 0.0243
804 OSTEONECROSIS OF JAW 601 0.0243
805 ACCIDENT 290 0.0243
806 INJECTION SITE ERYTHEMA 3012 0.0243
807 NEOPLASM 279 0.0242
808 ANGER 818 0.0242
809 CHOLECYSTITIS 288 0.0242
810 EMOTIONAL DISORDER 738 0.0239
811 SICKLE CELL ANAEMIA WITH CRISIS 377 0.0239
812 HYPOKALAEMIA 1102 0.0239
813 ADVERSE EVENT 2195 0.0238
814 THERAPEUTIC RESPONSE DECREASED 1444 0.0238
815 PULMONARY ARTERIAL HYPERTENSION 345 0.0238
816 DRUG EFFECT INCOMPLETE 862 0.0237
817 NEUTROPHIL COUNT DECREASED 967 0.0237
818 PARALYSIS 339 0.0237
819 GLYCOSYLATED HAEMOGLOBIN INCREASED 596 0.0236
820 RESTLESSNESS 859 0.0234
821 PRODUCT TASTE ABNORMAL 317 0.0234
822 INTENTIONAL PRODUCT MISUSE 2040 0.0233
823 DERMATITIS 488 0.0233
824 DIABETES MELLITUS INADEQUATE CONTROL 412 0.0232
825 GASTROINTESTINAL HAEMORRHAGE 1944 0.0232
826 UNDERDOSE 1697 0.0232
827 PELVIC PAIN 421 0.0231
828 UVEITIS 312 0.0230
829 HAEMATURIA 784 0.0229
830 PANCREATITIS 1209 0.0229
831 INJECTION SITE PAIN 7009 0.0228
832 BLOOD GLUCOSE ABNORMAL 421 0.0228
833 FLUID OVERLOAD 330 0.0227
834 MOOD SWINGS 722 0.0226
835 GENERALISED OEDEMA 280 0.0226
836 NEOPLASM PROGRESSION 784 0.0225
837 PHARYNGEAL OEDEMA 346 0.0225
838 TREATMENT NONCOMPLIANCE 1230 0.0225
839 PAIN OF SKIN 604 0.0224
840 EOSINOPHILIA 393 0.0224
841 MULTIPLE FRACTURES 368 0.0224
842 BLOOD GLUCOSE DECREASED 1074 0.0223
843 TACHYCARDIA 1986 0.0223
844 HYPERTHYROIDISM 322 0.0222
845 PRODUCT AVAILABILITY ISSUE 502 0.0220
846 COMPLICATION ASSOCIATED WITH DEVICE 320 0.0220
847 INJECTION SITE SWELLING 1676 0.0219
848 INJECTION SITE WARMTH 449 0.0218
849 MENTAL DISORDER 944 0.0217
850 INJECTION SITE HAEMORRHAGE 1727 0.0216
851 SUICIDAL IDEATION 1978 0.0216
852 UNRESPONSIVE TO STIMULI 552 0.0214
853 PRODUCT ADMINISTRATION ERROR 432 0.0214
854 PARANOIA 368 0.0213
855 METASTASES TO LIVER 371 0.0211
856 RASH GENERALISED 546 0.0211
857 CARDIOMYOPATHY 303 0.0205
858 BONE LOSS 308 0.0205
859 HAEMORRHAGE 2138 0.0204
860 DISEASE RECURRENCE 969 0.0203
861 PALLOR 554 0.0203
862 DISEASE PROGRESSION 2407 0.0203
863 CEREBROVASCULAR ACCIDENT 3422 0.0202
864 VISUAL ACUITY REDUCED 671 0.0202
865 TOOTH LOSS 416 0.0200
866 DRUG INEFFECTIVE 26280 0.0199
867 PRODUCT PHYSICAL ISSUE 402 0.0199
868 WITHDRAWAL SYNDROME 833 0.0198
869 SINUS TACHYCARDIA 281 0.0198
870 NEEDLE ISSUE 575 0.0197
871 INTERNATIONAL NORMALISED RATIO INCREASED 563 0.0197
872 ASCITES 579 0.0197
873 PROTEINURIA 374 0.0197
874 DEVICE ISSUE 1759 0.0196
875 COAGULOPATHY 326 0.0195
876 ARRHYTHMIA 925 0.0195
877 LIVER FUNCTION TEST ABNORMAL 566 0.0194
878 GENERALISED TONIC-CLONIC SEIZURE 322 0.0194
879 MEDICATION ERROR 1080 0.0194
880 COLON CANCER 289 0.0194
881 DRUG ERUPTION 343 0.0193
882 SUBDURAL HAEMATOMA 277 0.0193
883 PRODUCT QUALITY ISSUE 2603 0.0191
884 PSYCHOMOTOR HYPERACTIVITY 317 0.0191
885 PNEUMONITIS 520 0.0191
886 LYMPHOMA 295 0.0191
887 DRUG EFFECT DECREASED 1027 0.0190
888 BLINDNESS 771 0.0189
889 HYPONATRAEMIA 1060 0.0188
890 DEVICE FAILURE 286 0.0188
891 BLOOD GLUCOSE INCREASED 3536 0.0187
892 AGITATION 1375 0.0187
893 MANIA 308 0.0187
894 ERECTILE DYSFUNCTION 479 0.0186
895 INCORRECT PRODUCT ADMINISTRATION DURATION 399 0.0184
896 BLOOD BILIRUBIN INCREASED 497 0.0184
897 FEBRILE NEUTROPENIA 1204 0.0181
898 VAGINAL HAEMORRHAGE 783 0.0180
899 ACUTE MYOCARDIAL INFARCTION 527 0.0179
900 INCORRECT DOSE ADMINISTERED 4075 0.0178
901 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 416 0.0178
902 ABNORMAL BEHAVIOUR 704 0.0178
903 ACNE 1330 0.0175
904 EXPIRED PRODUCT ADMINISTERED 576 0.0173
905 OSTEONECROSIS 566 0.0172
906 RESPIRATORY FAILURE 1254 0.0172
907 DRUG LEVEL INCREASED 281 0.0170
908 BRADYCARDIA 898 0.0169
909 RESPIRATORY DISTRESS 465 0.0168
910 HYPERGLYCAEMIA 612 0.0168
911 LEUKOPENIA 838 0.0167
912 HAEMATEMESIS 424 0.0167
913 PRODUCT PRESCRIBING ERROR 397 0.0166
914 NEOPLASM MALIGNANT 1112 0.0166
915 ENCEPHALOPATHY 406 0.0165
916 INCORRECT DRUG ADMINISTRATION DURATION 463 0.0164
917 DERMATITIS ATOPIC 864 0.0164
918 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 896 0.0163
919 SKIN BURNING SENSATION 1159 0.0162
920 TRANSAMINASES INCREASED 354 0.0159
921 ANAPHYLACTIC REACTION 879 0.0159
922 WRONG TECHNIQUE IN DRUG USAGE PROCESS 576 0.0158
923 PANCYTOPENIA 885 0.0158
924 DEVICE DISLOCATION 687 0.0158
925 HYPOGLYCAEMIA 763 0.0157
926 SEDATION 410 0.0156
927 HYPERKALAEMIA 545 0.0155
928 NEUTROPENIA 2105 0.0155
929 DRUG INTERACTION 2441 0.0154
930 APPLICATION SITE PRURITUS 349 0.0154
931 NERVOUS SYSTEM DISORDER 480 0.0154
932 MALIGNANT NEOPLASM PROGRESSION 1571 0.0153
933 THROMBOCYTOPENIA 1711 0.0153
934 APPLICATION SITE PAIN 337 0.0153
935 GAMMA-GLUTAMYLTRANSFERASE INCREASED 332 0.0150
936 CEREBRAL HAEMORRHAGE 535 0.0149
937 PANCREATITIS ACUTE 334 0.0148
938 APPLICATION SITE ERYTHEMA 388 0.0148
939 SEPTIC SHOCK 643 0.0148
940 MYOCARDIAL INFARCTION 2574 0.0147
941 SKIN IRRITATION 675 0.0147
942 MELAENA 324 0.0147
943 DEVICE MALFUNCTION 1032 0.0147
944 ACCIDENTAL OVERDOSE 536 0.0146
945 MENORRHAGIA 284 0.0144
946 PRODUCT PRESCRIBING ISSUE 315 0.0144
947 PRODUCT DISPENSING ERROR 312 0.0143
948 CARDIAC FAILURE 1146 0.0143
949 PSYCHOTIC DISORDER 418 0.0141
950 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2864 0.0141
951 EXPOSURE VIA SKIN CONTACT 366 0.0141
952 INTERSTITIAL LUNG DISEASE 670 0.0138
953 RENAL FAILURE ACUTE 585 0.0138
954 EXTRA DOSE ADMINISTERED 555 0.0137
955 AGGRESSION 664 0.0133
956 BREAST CANCER 1220 0.0131
957 DRUG ADMINISTRATION ERROR 400 0.0130
958 LUNG NEOPLASM MALIGNANT 523 0.0127
959 ELECTROCARDIOGRAM QT PROLONGED 450 0.0125
960 DEATH 10736 0.0124
961 BLOOD CREATINE PHOSPHOKINASE INCREASED 358 0.0124
962 EMOTIONAL DISTRESS 1444 0.0119
963 ABORTION SPONTANEOUS 477 0.0119
964 DEPRESSED LEVEL OF CONSCIOUSNESS 470 0.0119
965 BREAST CANCER FEMALE 316 0.0118
966 JAUNDICE 318 0.0118
967 CARDIAC ARREST 966 0.0117
968 COMA 549 0.0115
969 METABOLIC ACIDOSIS 366 0.0114
970 DEVICE LEAKAGE 490 0.0113
971 MUCOSAL INFLAMMATION 284 0.0108
972 PRODUCT ADHESION ISSUE 381 0.0107
973 RESPIRATORY ARREST 286 0.0104
974 ANGIOEDEMA 457 0.0103
975 MULTIPLE ORGAN DYSFUNCTION SYNDROME 291 0.0103
976 HEPATIC FAILURE 307 0.0102
977 CONVULSION 576 0.0101
978 FOETAL EXPOSURE DURING PREGNANCY 761 0.0094
979 DEVICE BREAKAGE 368 0.0091
980 ACCIDENTAL EXPOSURE TO PRODUCT 897 0.0087
981 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 390 0.0083
982 RHABDOMYOLYSIS 348 0.0083
983 NO ADVERSE EVENT 1392 0.0077
984 PROSTATE CANCER 601 0.0075
985 CARDIO-RESPIRATORY ARREST 303 0.0072
986 PRODUCT STORAGE ERROR 621 0.0071
987 OVERDOSE 1501 0.0070
988 SUICIDE ATTEMPT 418 0.0069
989 DRUG WITHDRAWAL SYNDROME 581 0.0066
990 TOXICITY TO VARIOUS AGENTS 995 0.0059
991 DEVICE DIFFICULT TO USE 358 0.0054
992 DRUG DOSE OMISSION BY DEVICE 296 0.0038
993 DRUG DEPENDENCE 541 0.0034